Marshall Wace’s Cardiovascular Systems, Inc. CSII Stock Holding History

Marshall Wace’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-52,011	Closed	-$720K	–	3650
2022 Q3	$720K	Buy	+52,011	New	+$772K	﹤0.01%	2567
2022 Q2	–	Sell	-14,277	Closed	-$323K	–	4013
2022 Q1	$323K	Sell	14,277 -60,173	-81%	-$1.17M	﹤0.01%	2945
2021 Q4	$1.4M	Buy	74,450 +66,492	+836%	+$1.78M	﹤0.01%	2286
2021 Q3	$261K	Sell	7,958 -1,647	-17%	-$61.4K	﹤0.01%	2706
2021 Q2	$410K	Hold	9,605	–	–	﹤0.01%	2221
2021 Q1	$368K	Sell	9,605 -46,699	-83%	-$1.99M	﹤0.01%	2054
2020 Q4	$2.46M	Sell	56,304 -91,314	-62%	-$3.44M	0.01%	862
2020 Q3	$5.81M	Buy	147,618 +10,886	+8%	+$352K	0.04%	465
2020 Q2	$4.32M	Buy	+136,732	New	+$5.11M	0.03%	524
2018 Q4	–	Sell	-23,272	Closed	-$911K	–	1880
2018 Q3	$911K	Buy	+23,272	New	+$860K	0.01%	833
2017 Q1	–	Sell	-44,553	Closed	-$1.08M	–	829
2016 Q4	$1.08M	Buy	+44,553	New	+$1.09M	0.01%	745
2015 Q3	–	Sell	-33,074	Closed	-$875K	–	1096
2015 Q2	$875K	Buy	+33,074	New	+$1.07M	0.01%	616

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Marshall Wace's CSII Position: Q4 2022 in Review

Marshall Wace sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2022, closing a stake of 52,011 shares — an estimated $720K sold.

Marshall Wace first reported a position in CSII in Q2 2015 and held it in 12 quarters. The position peaked at $5.81M in Q3 2020. 161 funds tracked by Wall St. Rank hold CSII as of Q4 2022.

Marshall Wace reported no remaining Cardiovascular Systems, Inc. position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 52,011 Cardiovascular Systems, Inc. shares in Q4 2022, an estimated $720K.
Marshall Wace first reported a position in Cardiovascular Systems, Inc. in Q2 2015 and held it in 12 quarters.
Marshall Wace's Cardiovascular Systems, Inc. position peaked at $5.81M in Q3 2020.
161 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.